Weil is representing funds managed by Blackstone Tactical Opportunities in connection with Galderma’s agreement to acquire ZO® Skin Health, a leading physician-dispensed skincare brand built on clinical science and protocol-based daily care, from its shareholders, including Blackstone and the Obagi family.

The Weil team is led by Private Equity partner Jenna McBain and includes counsel Nicole Chen and associates Jace Krakovitz and Thandi Mallowah; Banking & Finance Co-Head Andrew Colao, partner Jackie Oveissi, counsel Libby Vinson and associate Nicole Reynolds; Executive Compensation & Benefits partner Victoria Rosamond and associate Amanda Nowak; Tax partner Chayim Neubort and associate Sarah Yue; Antitrust partners Jeff White and Kristin Sanford, counsel Marie-Marie de Fays and associates Meghana Appalaraju, Caren Andrango Espin and Nya Gavin; Technology & IP Transactions partner Dennis Adams and associate Taya Bokert; U.S. Privacy & Cybersecurity Head Olivia Greer; Employment partner Rebecca Sivitz and associate Clare Godfryd; Regulatory Transactions partners Seth Kerschner, Matthew Morton, John O’Loughlin and Billy Phalen and associate Caleb Holland; Complex Commercial Litigation partner Jessica Falk; Securities Litigation partner Matthew Connors; and Structured Finance & Derivatives partner Ariel Kronman.